Entry

D06718            Crude     Drug

Name

Red ginseng (JP18);
Powdered red ginseng (Non-JPS);
Red Ginseng (TN)

Component

Ginsenoside [CPD:C08944 C08945], Acetylene derivative, Sesquiterpene, Lignan, Peptide glucan, Choline [CPD:C00114], beta-Elemene [CPD:C17094], Panaxynol [CPD:C17447]

Source

Panax ginseng [TAX:4054]

Remark

Therapeutic category:

5100

Product:

D06718<JP>

Efficacy

Analeptic, Hypoglycemic, Sedative

Comment

Araliaceae (ginseng family) Panax ginseng root (steamed, dried)
Major component: Ginsenoside [CPD:C08944 C08945]
Powdered product: Standards for non-pharmacopoeial crude drugs

Brite

Therapeutic category of drugs in Japan [BR:br08301]
5  Crude drugs and Chinese medicine formulations
  51  Crude drugs
   510  Crude drugs
    5100  Crude drugs
     D06718  Red ginseng (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Nourishing tonics and health supplements
  46 Crude drugs
   D06718  Red ginseng (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
  Crude drugs
   Red ginseng
    D06718  Red ginseng (JP18)
Crude drugs [BR:br08305]
Dicot plants: asterids
  Araliaceae (ginseng family)
   D06718  Red ginseng
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
  D06718  Red ginseng
Crude drugs (non-JPS)
  D06718  Powdered red ginseng

Other DBs

PubChem:

47208369